What is the recommended dose of norepinephrine for a critically ill adult with septic shock or severe hypotension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Norepinephrine Dosing in Septic Shock

Start norepinephrine at 0.1–0.5 mcg/kg/min (approximately 7–35 mcg/min in a 70-kg adult) and titrate to achieve a mean arterial pressure (MAP) of 65 mmHg. 1

Initial Dosing and Administration

  • Begin norepinephrine at 0.1–0.5 mcg/kg/min, which translates to approximately 7–35 mcg/min in a 70-kg patient, and titrate upward to achieve your MAP target. 1

  • Administer through central venous access whenever possible to minimize the risk of tissue necrosis from extravasation. 1, 2

  • Place an arterial catheter for continuous blood pressure monitoring as soon as practical—this is essential for all patients requiring vasopressors. 2

  • Target a MAP ≥65 mmHg in most patients, though consider higher targets (70-75 mmHg) in those with chronic hypertension. 1, 2

Timing of Initiation

  • Start norepinephrine early—as soon as hypotension persists after initial fluid resuscitation (minimum 30 mL/kg crystalloid in first 3 hours), rather than waiting to complete all fluid administration. 2, 3, 4

  • In patients with profound, life-threatening hypotension (systolic BP <80 mmHg or diastolic BP ≤40 mmHg), initiate norepinephrine simultaneously with fluid resuscitation rather than delaying. 3, 5

  • Early norepinephrine administration (within 93 minutes vs 192 minutes) significantly increases shock control rates by 6 hours (76.1% vs 48.4%) and reduces complications like pulmonary edema and arrhythmias. 4

Escalation Strategy for Refractory Hypotension

When norepinephrine alone fails to achieve target MAP despite adequate fluid resuscitation, follow this algorithmic approach:

First Escalation: Add Vasopressin

  • Add vasopressin at 0.03 units/minute (range 0.01-0.03 units/min) when norepinephrine requirements remain elevated or reach 0.25-0.50 mcg/kg/min. 1, 2, 6

  • Vasopressin should never be used as monotherapy—it must be added to norepinephrine, not used alone. 1, 2

  • Do not exceed 0.03-0.04 units/minute except as salvage therapy, as higher doses cause cardiac, digital, and splanchnic ischemia without additional benefit. 2, 7

Second Escalation: Add Epinephrine

  • If target MAP remains unachieved despite norepinephrine plus vasopressin, add epinephrine as a third agent rather than increasing vasopressin beyond 0.03-0.04 units/min. 1, 2

  • Epinephrine dosing typically starts at 0.1-0.5 mcg/kg/min and is titrated to effect. 1

Consider Dobutamine for Persistent Hypoperfusion

  • Add dobutamine (2.5-20 mcg/kg/min) if persistent hypoperfusion exists despite adequate MAP and vasopressor therapy, particularly when myocardial dysfunction is evident (elevated cardiac filling pressures, low cardiac output). 1, 2

Critical Agents to Avoid

  • Do not use dopamine except in highly selected patients with low risk of tachyarrhythmias or absolute/relative bradycardia—it is associated with higher mortality and more arrhythmias compared to norepinephrine. 1, 2

  • Never use low-dose dopamine for renal protection—this is strongly discouraged and has no benefit. 1, 2

  • Avoid phenylephrine except in specific circumstances: when norepinephrine causes serious arrhythmias, when cardiac output is documented to be high with persistently low blood pressure, or as salvage therapy when all other agents have failed. 2

Monitoring Beyond Blood Pressure

  • Assess tissue perfusion markers beyond just MAP: lactate clearance, urine output ≥0.5 mL/kg/hr, mental status, capillary refill, and skin temperature. 2, 7

  • Monitor for signs of excessive vasoconstriction: cold extremities, digital ischemia, decreased urine output, rising lactate, or worsening organ dysfunction despite adequate MAP. 2

Common Pitfalls to Avoid

  • Do not delay norepinephrine initiation waiting to complete entire fluid resuscitation if life-threatening hypotension is present—prolonged hypotension independently increases mortality. 8, 3, 5

  • Do not mix norepinephrine with sodium bicarbonate or other alkaline solutions in the IV line, as adrenergic agents are inactivated in alkaline solutions. 1

  • If extravasation occurs, immediately infiltrate 5-10 mg of phentolamine diluted in 10-15 mL of saline into the site to prevent tissue necrosis and sloughing. 1

  • Do not rely solely on norepinephrine dose thresholds for adding vasopressin—consider additional factors like obesity (negatively associated with vasopressin response), hyperlactatemia, and acidosis when deciding to add adjunctive therapy. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.

American journal of respiratory and critical care medicine, 2019

Research

Early norepinephrine use in septic shock.

Journal of thoracic disease, 2020

Guideline

Norepinephrine Tapering and Vasopressin Addition Protocol

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Norepinephrine in septic shock: when and how much?

Current opinion in critical care, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.